 Westport, CT, April 08, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. Nasdaq: BSGM BioSig or the Company, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the PURE EPTM System was highlighted in a feature interview for the April issue of EP Lab Digest, a leading industry publication for electrophysiology professionals. 